Search Results - "Robuschi, Alessandro"

Abstract PO-065: Artificial intelligence to improve selection for NSCLC patients treated with immunotherapy by Prelaj, Arsela, Boeri, Mattia, Robuschi, Alessandro, Proto, Claudia, Russo, Giuseppe Lo, Ferrara, Roberto, Galli, Giulia, De Toma, Alessandro, Brambilla, Marta, Occhipinti, Mario, Manglaviti, Sara, Labianca, Alice, Beninato, Teresa, Bini, Marta, Mensah, Mavis, Ganzinelli, Monica, Zilembo, Nicoletta, de Braud, Filippo, Sozzi, Gabriella, Restelli, Marcello, Pedrocchi, Alessandra, Garassino, Marina Chiara, Trovo, Francesco

“…Introduction In advanced Non-Small Cell Lung Cancer (aNSCLC), Programmed Death Ligand 1 (PD-L1) remains the only used biomarker to candidate patients (pts) to…”
Get full text

Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy by Prelaj, Arsela, Boeri, Mattia, Robuschi, Alessandro, Ferrara, Roberto, Proto, Claudia, Lo Russo, Giuseppe, Galli, Giulia, De Toma, Alessandro, Brambilla, Marta, Occhipinti, Mario, Manglaviti, Sara, Beninato, Teresa, Bottiglieri, Achille, Massa, Giacomo, Zattarin, Emma, Gallucci, Rosaria, Galli, Edoardo Gregorio, Ganzinelli, Monica, Sozzi, Gabriella, de Braud, Filippo G M, Garassino, Marina Chiara, Restelli, Marcello, Pedrocchi, Alessandra Laura Giulia, Trovo', Francesco

“…(1) Background: In advanced non-small cell lung cancer (aNSCLC), programmed death ligand 1 (PD-L1) remains the only biomarker for candidate patients to…”
Get full text